# Low Dose Radiation Therapy for Glioblastoma Multiforme

> **NCT01466686** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 31 (actual)

## Conditions studied

- High Grade Glioma

## Interventions

- **RADIATION:** Low Dose Fractionated Radiation Therapy (LDFRT)
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT01466686
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466686, "Low Dose Radiation Therapy for Glioblastoma Multiforme". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01466686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*